What is the global market size of Oligonucleotide Synthesis Market?

Oligonucleotide Synthesis Market size was valued at USD 4.1 Billion in 2021 and is poised to grow from USD 4.60 Billion in 2022 to USD 11.46 Billion by 2030, at a CAGR of 12.10% during the forecast period (2023-2030).

Who are the key vendors in the Global Oligonucleotide Synthesis Market?

The global oligonucleotide synthesis market is highly competitive and fragmented, with a large number of players operating in the market. The oligonucleotide synthesis market is driven by strategic initiatives such as collaborations, partnerships, and mergers and acquisitions. The oligonucleotide synthesis market is expected to witness intense competition among players, with a focus on innovation, product differentiation, and expansion of geographical presence. 'Agilent Technologies, Inc. (US)', 'BioAutomation Corporation (US)', 'Biosearch Technologies, Inc. (US)', 'Biolytic Lab Performance Inc. (Canada)', 'Eurofins Genomics LLC (US)', 'General Electric Company (US)', 'GenScript Biotech Corporation (China)', 'Integrated DNA Technologies, Inc. (US)', 'Kaneka Eurogentec S.A. (Belgium)', 'LGC Limited (UK)', 'Merck KGaA (Germany)', 'Nitto Denko Avecia Inc. (US)', 'Thermo Fisher Scientific Inc. (US)', 'TriLink BioTechnologies, LLC (US)', 'Twist Bioscience Corporation (US)', 'ATDBio Ltd. (UK)', 'Axil Scientific Pte Ltd. (Singapore)', 'Biogen International GmbH (Switzerland)', 'Biomer Technology LLC (US)', 'Bio-Synthesis, Inc. (US)'

What is the key driver of Global Oligonucleotide Synthesis Market?

The growing demand for oligonucleotides in drug development and diagnostics is a key driver of the global oligonucleotide synthesis market. PCR primers, antisense oligonucleotides, and siRNA are just a few examples of oligonucleotides that are widely used in drug development and diagnostics.

What is the key market trend for Global Oligonucleotide Synthesis Market?

Increasing Demand for Customized Oligonucleotides: There has been a growing demand for customized oligonucleotides, which are tailored to specific applications. Customized oligonucleotides are used in various applications, including research, diagnostics, and therapeutics. The growing demand for customized oligonucleotides is attributed to the increasing use of oligonucleotides in drug discovery and development, genetic testing, and personalized medicine. For instance, Integrated DNA Technologies, a leading provider of customized oligonucleotides, offers a wide range of oligonucleotides for research, diagnostics, and therapeutic applications.

Which region accounted for the largest share in Global Oligonucleotide Synthesis Market?

North America dominated the global oligonucleotide synthesis market owing to the presence of major pharmaceutical and biotech companies in the region. The high adoption of advanced genomic technologies and the availability of a skilled workforce for the development of novel therapeutics is further projected to help this region continue dominance during the forecast period.

Oligonucleotide Synthesis Market Size, Share, Growth Analysis, By Product(Oligonucleotide-based Drugs (Antisense Oligonucleotide-based drug, siRNA oligonucleotide-based drug, Other oligonucleotide-based drug), Synthesized Oligonucleotides (Primers), By Application(Therapeutic Applications (Disease Type (Neurological Disorders, Rare Diseases, Other Diseases)), Research Applications (PCR), By End User(Hospitals, Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, CROs and CMOs), By Region - Industry Forecast 2024-2031

Report ID: SQMIG35H2107 | Region: Global | Published Date: September, 2024
Pages: 219 | Tables: 67 | Figures: 75

Oligonucleotide Synthesis Market Regional Insights

North America is projected to account for a dominant share of the global oligonucleotide synthesis market. The presence of a strong medical research infrastructure, supportive government funding for research, and rising use of genetic treatments are helping this region maintain its high market share. The United States and Canada are estimated to be the leading markets in this region as incidence of chronic diseases rises in these countries. The presence of leading pharmaceutical and biotechnology companies will also promote the demand for oligonucleotide synthesis in this region.

The surging prevalence demand for precision medicine in the Asia Pacific region makes it the fastest-growing market for oligonucleotide synthesis companies in the world. Increasing investments in genetic research and rising awareness regarding the benefits of gene therapies and therapeutics are expected to bolster market growth in this region. Increasing geriatric population and rising healthcare expenditure will also create new opportunities for oligonucleotide synthesis companies in the Asia Pacific region. Japan, China, and India will be the leading markets for oligonucleotide synthesis providers in this region.

Oligonucleotide Synthesis Market Report Snapshots

License Type Top market research company in USA

File Type

$5,300

BUY NOW GET FREE SAMPLE

Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Oligonucleotide Synthesis Market size was valued at around USD 6 billion in 2022 and is expected to rise from USD 7.3 billion in 2023 to reach a value of USD 26.3 billion by 2031, at a CAGR of 17.4% over the forecast period (2024–2031).

Investing in the development of oligonucleotide synthesis for different disease indications should remain the prime focus of all companies. Reducing the costs of synthesis will be a major area of interest for all oligonucleotide synthesis providers to improve their profitability. Utilizing supportive government initiatives and funding to maximize R&D scope will also be a popular strategy for oligonucleotide synthesis market players in the future. 'Danaher Corporation ', 'Thermo Fisher Scientific Inc. ', 'Merck KGaA ', 'Eurofins Scientific ', 'Agilent Technologies, Inc. ', 'Kaneka Corporation ', 'Azenta, Inc. ', 'Sarepta Therapeutics, Inc. ', 'AstraZeneca ', 'Astellas Pharma Inc. ', 'Jazz Pharmaceuticals PLC ', 'Nippon Shinyaku, Co. Ltd. (NS Pharma, Inc.) ', 'Ionis Pharmaceuticals, Inc. ', 'Novartis AG ', 'OligoMaker ApS (Part of TAG Copenhagen A/S) ', 'Biolegio BV ', 'Biolytic Lab Performance, Inc. ', 'Bio-Synthesis, Inc. ', 'Creative Biogene ', 'Reprocell, Inc.'

Oligonucleotides play a key role in diagnostic tools such as PCR, qPCR, and next-generation sequencing (NGS) and demand for early diagnostics is increasing rapidly. This factor is projected to create new opportunities for oligonucleotide synthesis market growth going forward.

Use of AI and Automation: Automation and artificial intelligence are being integrated into oligonucleotide synthesis processes, to enhance the accuracy and scalability of the process. Automated synthesizers and AI-driven design tools are projected to be highly popular as they can assist in cost reduction as well.

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

Oligonucleotide Synthesis Market Regional Insights

Oligonucleotide Synthesis Market Report Snapshots

Want to customize this report?

FAQs

What is the global market size of Oligonucleotide Synthesis Market?

Who are the key vendors in the Oligonucleotide Synthesis Market?

What is the key driver of Oligonucleotide Synthesis Market?

What is the key market trend for Oligonucleotide Synthesis Market?

Which region accounted for the largest share in Oligonucleotide Synthesis Market?

Request Free Customization

Related Reports

Feedback From Our Clients

$5,300